Abp ε Inhibitors
Abp ε inhibitors are a specialized class of chemical compounds designed to target and inhibit the activity of the Abp ε protein, which is a member of the ATP-binding cassette (ABC) transporter family. ABC transporters play a crucial role in cellular processes by using ATP hydrolysis to transport various substrates, such as ions, lipids, and small molecules, across cellular membranes. Abp ε is thought to be involved in the transport of specific substrates that are essential for maintaining cellular balance and homeostasis. Inhibitors of Abp ε are designed to block the transport activity by interfering with the protein's ability to bind or hydrolyze ATP, thereby preventing the energy-driven transport of substrates across the membrane. This inhibition affects the cellular processes that rely on the proper functioning of Abp ε for molecular transport.
The chemical diversity of Abp ε inhibitors includes small molecules and more complex compounds, all tailored to interact with specific regions of the Abp ε protein. These inhibitors typically bind to the ATP-binding domain, preventing the necessary hydrolysis of ATP that fuels the transport process. Some inhibitors may work by targeting the transmembrane domain, where substrate binding and translocation occur, thus preventing the conformational changes required for transport. Inhibitors can also cause allosteric effects, altering the structure of Abp ε in a way that disrupts its function without directly blocking the active site. By modulating the activity of Abp ε, these inhibitors serve as valuable tools for studying the molecular mechanisms of ABC transporters and their role in controlling the movement of critical substrates within cells. The use of Abp ε inhibitors helps researchers understand how these transporters contribute to cellular homeostasis and other fundamental biological processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
As a synthetic nonsteroidal estrogen, Diethylstilbestrol can bind to estrogen receptors, altering the expression of certain genes, including those encoding sex hormone-binding globulin (SHBG), leading to functional inhibition of SHBG's binding capacity. | ||||||
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $47.00 $156.00 $171.00 $525.00 $941.00 | 4 | |
Flutamide acts as an antiandrogen by binding to androgen receptors and inhibiting their interaction with natural ligands. This inhibition can decrease the levels of androgens that regulate SHBG production, thereby decreasing SHBG's activity. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole inhibits cytochrome P450 enzymes involved in steroid biosynthesis, reducing the synthesis of androgens and estrogens that can regulate SHBG levels and activity, thus decreasing SHBG's ability to bind sex hormones. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone, as an aldosterone antagonist, has secondary actions on androgen receptors, which may lead to a decrease in androgens that control the activity of SHBG, subsequently leading to a functional inhibition of SHBG's hormone-binding ability. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
Finasteride selectively inhibits the enzyme 5-alpha-reductase, which is responsible for the conversion of testosterone to dihydrotestosterone (DHT). Lower DHT levels can lead to altered SHBG activity, inhibiting its capacity to bind hormones. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
Bicalutamide binds to androgen receptors and inhibits their activity, which can lead to a decrease in androgen-regulated production of SHBG, therefore inhibiting SHBG's function in binding sex hormones. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Letrozole inhibits the aromatase enzyme, leading to a reduction in estrogen synthesis. Estrogens are known regulators of SHBG, so the inhibition of estrogen production by Letrozole can lead to a functional inhibition of SHBG's activity. | ||||||
Anastrozole | 120511-73-1 | sc-217647 | 10 mg | $92.00 | 1 | |
Anastrozole, another aromatase inhibitor, reduces estrogen levels, which in turn can decrease the hepatic synthesis of SHBG, inhibiting the ability of SHBG to bind and transport sex hormones. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen acts as a selective estrogen receptor modulator. By competing with estrogen at its receptor, Tamoxifen can indirectly lead to a decrease in SHBG levels and its activity through the modulation of estrogen-dependent signaling. | ||||||
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $134.00 $411.00 | ||
Exemestane is an irreversible steroidal aromatase inhibitor, which can decrease circulating estrogen levels. Reduced levels of estrogens can lead to decreased SHBG activity by influencing the synthesis of SHBG in the liver. | ||||||